FORMULATION AND EVALUATION OF CANDESARTAN CILEXETIL IMMEDIATE RELEASE TABLETS  

Journal Title: International Research Journal of Pharmacy (IRJP) - Year 2012, Vol 3, Issue 7

Abstract

Candesartan Cilexetil is an esterified prodrug of Candesartan, a non-peptide angiotensin II type-1(AT1) receptor antagonist used in the treatment of hypertension and congestive heart failure. Candesartan meets the requirement of high potency but it is poorly absorbed when administered orally. Therefore, the prodrug Candesartan Cilexetil is developed. It is soluble in methylene chloride, half life is 5.1 to 10.5hrs and bioavailability is 15%. It is marketed as conventional tablets. In this work, it is formulated as immediate release tablets by changing the concentration of ingredients. For many drug substances, conventional immediate-release formulations provide clinically effective therapy while maintaining the required balance of pharmacokinetic and pharmacodynamic profiles with in acceptable level of safety to the patient. The immediate release formulation of Candesartan Cilexetil is prepared by wet granulation method to provide rapid onset of action. In order to optimize the best formulation, ten different trials are developed. The main ingredients used in the formulation are lactose monohydrate, PEG, calcium CMC and MCC. Weight variation, thickness, friability, disintegration time, in-vitro release, pharmaceutical assay are studied as response variables. The formulation containing 38% of MCC is selected as an optimized product in which the different physical properties and in-vitro release profile showed best comparable results with innovator product. 

Authors and Affiliations

Neeharika Jampani , Ravi Bonthu , Mamatha Reddy

Keywords

Related Articles

FORMULATION AND DEVELOPMENT OF TOPICAL NIOSOMAL GEL OF BCS CLASS - III ANTI-VIRAL DRUG FOR BETTER EFFICACY AS HERPES TREATMENT  

The objective of present research work was to formulate niosomal gel of ACV and to evaluate it for enhancements of skin permeation and skin retention characteristics. ACV niosomes were prepared by classical thin layer hy...

EFFECT OF ETHYL ACETATE EXTRACT OF BLACK TEA ON CARDIOVASCULAR COMPLICATIONS ASSOCIATED WITH STREPTOZOTOCIN DIABETIC RATS 

Diabetes mellitus (DM) is associated with an increased incidence of cardiovascular events and microvascular complications. These complications contribute to the morbidity and mortality associated with the disease. There...

FORMULATION AND IN-VITRO EVALUATION OF TRAMADOL HYDROCHLORIDE FLOATING TABLETS 

Tramadol hydrochloride is a synthetic opioid used as a centrally acting analgesic and effective in both experimental and clinical pain. The half-life of the drug is about 5.5 hours and oral dose is 50 to 100 mg every 4 t...

DEVELOPMENT AND EVALUATION OF MUCOADHESIVE MICROCAPSULES OF NIMODIPINE  

In the present study, the development and evaluation of Mucoadhesive microcapsules of Nimodipine has been undertaken. Nimodipine is a calcium channel blocker used in the treatment of blood pressure, angina pectoris, and...

IMMUNOSTIMULATORY POTENTIAL OF DIETARY AMLA (PHYLLANTHUS EMBLICA) IN GROWTH AND HAEMATOLOGY OF TILAPIA MOSSAMBICUS CHALLENGED WITH PSEUDOMONAS AERUGINOSA 

The present study was carried out to evaluate the immunostimulant potential of Amla (Phyllanthus emblica). Formulated diets with different concentrations of ethanolic extract of P.emblica (D1=0%, D2=1% and D3=2%) were f...

Download PDF file
  • EP ID EP86883
  • DOI -
  • Views 128
  • Downloads 0

How To Cite

Neeharika Jampani, Ravi Bonthu, Mamatha Reddy (2012). FORMULATION AND EVALUATION OF CANDESARTAN CILEXETIL IMMEDIATE RELEASE TABLETS  . International Research Journal of Pharmacy (IRJP), 3(7), 271-284. https://europub.co.uk/articles/-A-86883